UB Paderborn / Katalog / Suche / in CDI

The VKORC1 and CYP2C9 gene variants as pharmacogenetic factors in acenocoumarol therapy in Serbian patients - consideration of hypersensitivity and resistance

Srpski arhiv za celokupno lekarstvo, 2022-03, Vol.150 (3-4), p.156-162

2022

Link zum Volltext

Verfügbarkeit prüfen

DNA and RNA Molecules as a Foundation of Therapy Strategies for Treatment of Cardiovascular Diseases

Pharmaceutics, 2023-08, Vol.15 (8), p.2141

Rakicevic, Ljiljana

2023

Link zum Volltext

Verfügbarkeit prüfen

Influence of Cyp2c192 Gene Variant on Therapeutic Response During Clopidogrel Treatment in Patients with Carotid Artery Stenosis

Journal of medical biochemistry, 2016-01, Vol.35 (1), p.26-33

2016

Link zum Volltext

Verfügbarkeit prüfen

The c.-1639g > A polymorphism of the VKORC1 gene and his influence on the therapeutic response during oral anticoagulants use

Vojnosanitetski pregled, 2009-08, Vol.66 (8), p.617-621

2009

Link zum Volltext

Verfügbarkeit prüfen

An overview of genetic risk factors in thrombophilia

Srpski arhiv za celokupno lekarstvo, 2010-01, Vol.138 Suppl 1 (suppl. 1), p.79-81

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetics of Clopidogrel Therapy and Neurointerventional Procedures: We Need Precision Data for Precision Medicine

Clinical pharmacology and therapeutics, 2019-03, Vol.105 (3), p.547-549

2019

Link zum Volltext

Verfügbarkeit prüfen

Economic analysis of pharmacogenomic-guided clopidogrel treatment in Serbian patients with myocardial infarction undergoing primary percutaneous coronary intervention

Pharmacogenomics, 2016-11, Vol.17 (16), p.1775-1784

2016

Link zum Volltext

Verfügbarkeit prüfen

Multi-tasking role of the mechanosensing protein Ankrd2 in the signaling network of striated muscle

PloS one, 2011-10, Vol.6 (10), p.e25519-e25519

2011

Link zum Volltext

Verfügbarkeit prüfen

Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium

Vojnosanitetski pregled, 2005, Vol.62 (3), p.201-205

2005

Link zum Volltext

Verfügbarkeit prüfen

Clopidogrel High On-Treatment Platelet Reactivity in Patients with Carotid Artery Stenosis Undergoing Endarterectomy. A Pilot Study

Current vascular pharmacology, 2016-11, Vol.14 (6), p.563

2016

Link zum Volltext

Verfügbarkeit prüfen

Does Anticoagulant Therapy Improve Pregnancy Outcome Equally, Regardless of Specific Thrombophilia Type?

Clinical and applied thrombosis/hemostasis, 2014-03, Vol.20 (2), p.184-189

2014

Link zum Volltext

Verfügbarkeit prüfen

The c.-1639G>A polymorphism of the VKORC1 gene in Serbian population: retrospective study of the variability in response to oral anticoagulant therapy

Blood coagulation & fibrinolysis, 2010-09, Vol.21 (6), p.558-563

2010

Link zum Volltext

Verfügbarkeit prüfen

Influence of Cyp2c192 Gene Variant on Therapeutic Response During Clopidogrel Treatment in Patients with Carotid Artery Stenosis/ Uticaj cyp2c192 varijante gena na terapijski odgovor u toku primene klopidogrela kod bolesnika sa stenozom karotidne arterije

Journal of medical biochemistry, 2016-01, Vol.35 (1), p.26-33

2016

Link zum Volltext

Verfügbarkeit prüfen

Extreme sensitivity to acenocoumarol therapy in patient with both VKORC.-1639 A/A and CYP2C91/3 genotypes

Journal of thrombosis and thrombolysis, 2011-10, Vol.32 (3), p.368-371

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetic tests could be helpful in predicting of VKA maintenance dose in elderly patients at treatment initiation

Journal of thrombosis and thrombolysis, 2013, Vol.35 (1), p.90-94

2013

Link zum Volltext

Verfügbarkeit prüfen

Rationalized DNA sequencing-based protocol for genotyping patients receiving coumarin therapy

Scandinavian journal of clinical and laboratory investigation, 2013-09, Vol.73 (6), p.523-527

2013

Link zum Volltext

Verfügbarkeit prüfen

Type and Location of Venous Thromboembolism in Carriers of Factor V Leiden or Prothrombin G20210A Mutation Versus Patients With No Mutation

Clinical and applied thrombosis/hemostasis, 2010-02, Vol.16 (1), p.66-70

2010

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for thrombosis in Serbian children

Blood coagulation & fibrinolysis, 2014-01, Vol.25 (1), p.25-32

2014

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel

European journal of clinical pharmacology, 2018-04, Vol.74 (4), p.443-451

2018

Link zum Volltext

Verfügbarkeit prüfen

The use of D-dimer with new cutoff can be useful in diagnosis of venous thromboembolism in pregnancy

European journal of obstetrics & gynecology and reproductive biology, 2010-01, Vol.148 (1), p.27-30

2010

Link zum Volltext

Verfügbarkeit prüfen

A novel role for cardiac ankyrin repeat protein Ankrd1/CARP as a co-activator of the p53 tumor suppressor protein

Archives of biochemistry and biophysics, 2010-10, Vol.502 (1), p.60-67

2010

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel

European journal of clinical pharmacology, 2018-04, Vol.74 (4), p.453-453

2018

Link zum Volltext

Verfügbarkeit prüfen

A successful outcome of pregnancy in a patient with congenital antithrombin deficiency

Vojnosanitetski pregled, 2011-02, Vol.68 (2), p.175-177

2011

Link zum Volltext

Verfügbarkeit prüfen

Differential expression and localization of Ankrd2 isoforms in human skeletal and cardiac muscles

Histochemistry and cell biology, 2016-11, Vol.146 (5), p.569-584

2016

Link zum Volltext

Verfügbarkeit prüfen

Prothrombotic Genetic Risk Factors in Stroke: A Possible Different Role in Pediatric and Adult Patients

Clinical and applied thrombosis/hemostasis, 2012-11, Vol.18 (6), p.658-661

2012

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

The VKORC1 and CYP2C9 gene variants as pharmacogenetic factors in acenocoumarol therapy in Serbian patients - consideration of hypersensitivity and resistance

DNA and RNA Molecules as a Foundation of Therapy Strategies for Treatment of Cardiovascular Diseases

Influence of Cyp2c192 Gene Variant on Therapeutic Response During Clopidogrel Treatment in Patients with Carotid Artery Stenosis

The c.-1639g > A polymorphism of the VKORC1 gene and his influence on the therapeutic response during oral anticoagulants use

An overview of genetic risk factors in thrombophilia

Pharmacogenetics of Clopidogrel Therapy and Neurointerventional Procedures: We Need Precision Data for Precision Medicine

Economic analysis of pharmacogenomic-guided clopidogrel treatment in Serbian patients with myocardial infarction undergoing primary percutaneous coronary intervention

Multi-tasking role of the mechanosensing protein Ankrd2 in the signaling network of striated muscle

Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium

Clopidogrel High On-Treatment Platelet Reactivity in Patients with Carotid Artery Stenosis Undergoing Endarterectomy. A Pilot Study

Does Anticoagulant Therapy Improve Pregnancy Outcome Equally, Regardless of Specific Thrombophilia Type?

The c.-1639G>A polymorphism of the VKORC1 gene in Serbian population: retrospective study of the variability in response to oral anticoagulant therapy

Influence of Cyp2c192 Gene Variant on Therapeutic Response During Clopidogrel Treatment in Patients with Carotid Artery Stenosis/ Uticaj cyp2c192 varijante gena na terapijski odgovor u toku primene klopidogrela kod bolesnika sa stenozom karotidne arterije

Extreme sensitivity to acenocoumarol therapy in patient with both VKORC.-1639 A/A and CYP2C91/3 genotypes

Pharmacogenetic tests could be helpful in predicting of VKA maintenance dose in elderly patients at treatment initiation

Rationalized DNA sequencing-based protocol for genotyping patients receiving coumarin therapy

Type and Location of Venous Thromboembolism in Carriers of Factor V Leiden or Prothrombin G20210A Mutation Versus Patients With No Mutation

Risk factors for thrombosis in Serbian children

Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel

The use of D-dimer with new cutoff can be useful in diagnosis of venous thromboembolism in pregnancy

A novel role for cardiac ankyrin repeat protein Ankrd1/CARP as a co-activator of the p53 tumor suppressor protein

Correction to: Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel

A successful outcome of pregnancy in a patient with congenital antithrombin deficiency

Differential expression and localization of Ankrd2 isoforms in human skeletal and cardiac muscles

Prothrombotic Genetic Risk Factors in Stroke: A Possible Different Role in Pediatric and Adult Patients

Suchergebnisse filtern